Parallax Volatility Advisers, L.P. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$946,844
+6.8%
25,4050.0%0.00%
+100.0%
Q4 2022$886,380
-79.9%
25,405
-67.8%
0.00%
-83.3%
Q3 2022$4,415,000
+182.1%
78,897
+160.9%
0.01%
+500.0%
Q2 2022$1,565,000
-57.9%
30,236
+9.1%
0.00%
-66.7%
Q3 2021$3,719,000
-82.4%
27,722
-78.7%
0.00%
-83.3%
Q2 2021$21,096,000
+2273.0%
130,301
+191.5%
0.02%
+1700.0%
Q3 2020$889,000
+15.0%
44,700
+58.0%
0.00%0.0%
Q2 2018$773,000
+1785.4%
28,295
+1221.0%
0.00%
Q4 2017$41,0002,1420.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders